| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |